Cellular Signalling 1990-01-01

Daurisoline derivatives inhibit the ability of calmodulin to stimulate cyclic nucleotide phosphodiesterase activity.

Z Y Hu, L M Xu, Y Sun, S L Chen, H M Cai

Index: Cell. Signal. 2(4) , 353-7, (1990)

Full Text: HTML

Abstract

Daurisoline alkaloid derivatives were found to be potent calmodulin (CaM) antagonists. The ability of daurisoline derivatives to attenuate the stimulatory effect on calmodulin activated cyclic nucleotides phosphodiesterase (CaM-PDE) was studied. These compounds did not inhibit the basal activity of this enzyme. The hydrophobicity of these compounds was related to their inhibitory potency. It is suggested that such drugs bind directly to calmodulin in a Ca2(+)-dependent fashion, as indicated by their ability to change calmodulin fluorescence.

Related Compounds

  • Daurisoline

Related Articles:

Pharmacokinetic-pharmacodynamic modeling of daurisoline and dauricine in beagle dogs.

2003-10-01

[Acta Pharmacol. Sin. 24(10) , 1011-5, (2003)]

Effects of daurisoline on intracellular Ca2+ activity in myocardium.

1996-05-01

[Zhongguo Yao Li Xue Bao 17(3) , 248-51, (1996)]

Effects of the putative P-type calcium channel blocker, R,R-(-)-daurisoline on neurotransmitter release.

1995-12-01

[Naunyn Schmiedebergs Arch. Pharmacol. 352(6) , 670-8, (1995)]

Effects of l-daurisoline on quinolinic acid-induced Ca2+ influx in hippocampus neurons in freely moving rats.

1991-07-01

[Zhongguo Yao Li Xue Bao 12(4) , 301-4, (1991)]

P-type calcium channels are blocked by the alkaloid daurisoline.

1994-07-21

[Neuroreport 5(12) , 1489-92, (1994)]

More Articles...